Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas
| Image |  |
|---|---|
| Description | scientific article published on 10 January 2019 |
| Author/s |
author: Elaine Jaffe Seth M Steinberg Wyndham H. Wilson Joseph Roswarski Stefania Pittaluga Christopher Melani Thomas Waldmann Mark Roschewski |
| Publication date | January 10, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |